MENU
JUN 17, 2020 6:00 AM PDT

Role of serology in the next phase of COVID-19 investigation and response

Sponsored by: GenScript
C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract

With more than 6 million infections and more than 300,000 deaths (as of end of May 2020), the current COVID-19 pandemic has led to large scale lockdown around the world to prevent further spread of the disease.

From the initial effort of rapid diagnosis and containment, the international community is now facing the challenge of an effective and pragmatic “exit” strategy to balance the public health risk versus the huge economic losses as a result of the travel ban and lockdown measures globally.

Among the many challenges of onging COVID-19 investigation and repsonses, the follwong three stands out as the most pressing: 1) A good understanding of protective immunity and longevity of immunity to better advise/design “exit” strategy and policy; 2) Rapid development and deployment of COVID-19 vaccine(s) and a reliable testing platform capable of assessing and monitoring vaccine efficacy en masse; and 3) Investigation of virus origin and the early animal-to-human transmission events to prevent future outbreaks.

Serology will play a key role in all three areas. In this presentation, different serological platforms currently used for COVID-19 testing will be reviewed and compared together with the introduction of a novel platfom, the surrogate virus neutralization test (sVNT), that we have developed recently.

Learning Objectives:
1. Challenges for next phase of COVID-19 outbreak

2. Role of serology in meeting some of these challenges


Show Resources
You May Also Like
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
JUN 29, 2022 8:00 AM PDT
JUN 29, 2022 8:00 AM PDT
Date: June 29, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) As of May 2022, there have been more than 500 million confirmed cases of COVID-19, including numerous variants. Additiona...
FEB 24, 2022 10:00 AM PST
C.E. CREDITS
FEB 24, 2022 10:00 AM PST
Date: February 24, 2021 Time: 10:00am (PST), 1:00pm (EST) One of the largest global public health crises is the rise of antimicrobial-resistant infections. Globally, over 700,000 people die...
Loading Comments...
Show Resources